Yahoo Web Search

Search results

1. www.businessnewsaustralia.com › articles › bailadorBailador invests $20m in telehealth startup Updoc

   www.businessnewsaustralia.com › articles › bailador

   • Cached

   1 day ago · The inclusion of Updoc in Bailador's portfolio adds to its other Australian health tech investments including Access Telehealth, men's health focused Mosh, and InstantScrips which it exited in mid-2023 year in a $135 million buyout from Wesfarmers (ASX: WES) subsidiary Australian Pharmaceutical Industries.

2. Images

   • 
   • 
   • 
   • 

   View all

3. www.medicalstartups.org › country › AustraliaTop 50 medical and healthcare startups in Australia

   www.medicalstartups.org › country › Australia

   • Cached

   5 days ago · 1. Synchron. Funding: $145M. Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. 2. Eucalyptus. Funding: $137.6M. Eucalyptus provides telehealth services in Australia. 3. Harrison.ai. Funding: $121.1M.

   • 
   • 
   • 
   • 

4. www.youtube.com › watchRegina Cowie - National Health Services Manager at Australian ...

   www.youtube.com › watch

   • Cached

   2 days ago · Regina Cowie is the national health care service manager at Australian Pharmaceutical Industries (API) (https://www.api.net.au/) - for brands such as Pricel...

   • Video Duration: 40 min

   • Author: Raven's Recruitment

5. Videos

   • 

     au.linkedin.com

     Australian Pharmaceutical Industries (API) | LinkedIn

     Mar 11, 2011

   • 

     2:13

     youtube.com

     Herrmann Customer Success Story - Australian Pharmaceutical Industries (Priceline)

     Nov 22, 2018

     985 Views

   • 

     study.uq.edu.au

     Master of Pharmaceutical Industry Practice - Study - The University of Queensland

     Jun 22, 2022

   View all

6. ispe.org › pharmaceutical-engineering › march-aprilNavigating the Asia Pacific Pharmaceutical Landscape for ...

   ispe.org › pharmaceutical-engineering › march-april

   • Cached

   5 days ago · APAC’s size and complexity has created new challenges and opportunities for the pharmaceutical industry as nations work together to meet the manufacturing needs for medical products. Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact | Pharmaceutical Engineering

7. www.psa.org.au › blogLatest highlights | Pharmaceutical Society of Australia

   www.psa.org.au › blog

   • Cached

   2 days ago · The Pharmaceutical Society of Australia (PSA) welcomes the Albanese Government’s 2024-25 federal budget, making healthcare more accessible to Australians through cost-of-living relief and expanded pharmacy programs. Australians will have access to cheaper medicines under the Pharmaceutical Benefits Scheme, with a freeze on indexation for at ...

8. People also ask

   How big is the Indian pharmaceutical industry?

   • The Indian pharmaceutical industry is a major player, not only in APAC, but globally. Some estimates value it at US $50 billion and expect rapid, continuous growth, supplying as much as 20% of the world’s generic medicines and 60% of global vaccine demand. 4 Indian companies received almost half of the 742 abbreviated

   Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact

   ispe.org/pharmaceutical-engineering/march-april-2024/navigating-asia-pacific-pharmaceutical-landscape-global

   See all results for this question

   Is the pharmaceutical industry growing in the Philippines?

   • “Over the last few years, the pharmaceutical industry in the Philippines has shown significant market growth potential,” said Arnel Cabungcal, Operations Services and Technology, Unilab, Inc., and past president of the ISPE Philippines Affiliate.

   Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact

   ispe.org/pharmaceutical-engineering/march-april-2024/navigating-asia-pacific-pharmaceutical-landscape-global

   See all results for this question

   Does Vietnam have a pharmaceutical industry?

   • Vietnam has a long history of pharmaceutical manufacturing. For example, Sanofi, which operates a GMP facility in Ho Chi Minh City, has had a presence in Vietnam for more than 70 years. “The pharmaceutical market in Vietnam still has growth potential with our population of more than 100 million,” said Bảo Nguyễn.

   Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact

   ispe.org/pharmaceutical-engineering/march-april-2024/navigating-asia-pacific-pharmaceutical-landscape-global

   See all results for this question

   Why is the biopharmaceutical industry so small in Asia?

   • As a result, contract research organizations are prevalent. Combined with their proximity to the abundance of relatively cheap labor in Asia, this means the traditional biopharmaceutical industry is quite small in both countries. “It’s true, we can’t compete in terms of low-cost labor,” Wakeham said.

   Navigating the Asia Pacific Pharmaceutical Landscape for Global Impact

   ispe.org/pharmaceutical-engineering/march-april-2024/navigating-asia-pacific-pharmaceutical-landscape-global

   See all results for this question

9. www.health.gov.au › our-work › electronic-prescribingElectronic prescribing | Australian Government Department of ...

   www.health.gov.au › our-work › electronic-prescribing

   • Cached

   5 days ago · The 2023-24 Budget announced $111.8 million over four years and $24.2 million ongoing funding to provide electronic prescription delivery infrastructure and related enhancements. This creates certainty for the exchange of nearly 300 million Pharmaceutical Benefits Scheme (PBS) prescriptions each year between prescribers and pharmacists.

10. simplywall.st › stocks › auWashington H. Soul Pattinson (ASX:SOL) - Simply Wall St

    simplywall.st › stocks › au

    • Cached

    5 days ago · Wesfarmers Limited (ASX:WES) completed the acquisition of Australian Pharmaceutical Industries Limited (ASX:API) from Washington H. Soul Pattinson and Company Limited (ASX:SOL) and others. Apr 01 Price target decreased to AU$27.40